Regulon

Regulon: R-17

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
130.80857310Pr-46Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
11338 ENSG00000063244 U2AF2 P26368
55658 ENSG00000070423 RNF126 A0A024R206
10139 ENSG00000101246 ARFRP1 Q13795
83743 ENSG00000105447 GRWD1 Q9BQ67
2077 ENSG00000105722 ERF P50548
2931 ENSG00000105723 GSK3A A0A024R0L5
56926 ENSG00000125912 NCLN Q969V3
5589 ENSG00000130175 PRKCSH K7ELL7
126208 ENSG00000142409 ZNF787 Q6DD87
79058 ENSG00000169696 ASPSCR1 Q9BZE9
79797 ENSG00000175213 ZNF408 Q9H9D4
10078 ENSG00000184281 TSSC4 Q9Y5U2
10025 ENSG00000282092 MED16 Q9Y2X0

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
LY-2090314GSK3BSmall moleculeINHIBITORGlycogen synthase kinase-3 alpha inhibitor20
LITHIUM CARBONATEIMPA1Small moleculeINHIBITORGlycogen synthase kinase-3 inhibitor40
LITHIUM CITRATEIMPA1Small moleculeINHIBITORGlycogen synthase kinase-3 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-17

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs